Herpes Awareness Day is October 13

We’re celebrating with the release of Herpes Cure Pipeline 3.0.

Herpes Cure Advocacy is the only patient advocacy organization globally tracking the clinical pipeline for HSV. If you want to get the news first – please subscribe to our newsletter by clicking here today.

Herpes Awareness Day Advocacy Alerts

Advocates, We need you to take action today to use your voice to advocate for change. How can you help today?

  1. Contact President’s Advisory Council on HIV/AIDS (PACHA) Chair
  2. Participate in 50 State Challenge

Details below!

1. White House Task Force for Herpes

In July 2023, Herpes Cure Advocacy organized a group letter asking President Biden for a White House task force to address Herpes Simplex Virus with a strategic and coordinated effort.

Again on September 29, Herpes Cure Advocacy asked PACHA for their support to bring this initiative to the White House.

Today, we’re asking PACHA Board Chair Marlene McNeese to support the Herpes Cure Advocacy request for a federal task force!

Sample Email to PACHA

2. 50 State Challenge UPDATE

Do you live in CT, WI, or elsewhere in the US and want to use your voice for change? Join us to participate in the 50 State Challenge! Herpes Cure Advocacy is organizing to collaborate with Herpes Advocates in all 50 States. 

We have 25 states covered and have just 25 more to go. We need you and your voice to help continue the momentum for change in Washington DC. Patients, professionals, scientists, HCPs, private industry, etc. are all welcome to answer the roll call. 

We need advocates in the following states: Arkansas, Connecticut, Delaware, Iowa, Idaho, Maine Minnesota, Missouri, Mississippi, Montana, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Ohio, Oklahoma, Rhode Island, South Dakota, Vermont, Wisconsin, West Virginia, Wyoming.

Want to help?

What we’re reading:

Strategic Plan for Herpes Simplex Virus Research 2023-2028

The Association Between Herpes Simplex Virus and Alzheimer’s Disease: A Systematic Review

Mpox and herpes simplex virus type 2 coinfection in a patient with human immunodeficiency virus

Epigallocatechin Gallate-Modified Silver Nanoparticles Show Antiviral Activity against Herpes Simplex Type 1 and 2

Herpes Simplex Virus Encephalitis after Recovery from Coronavirus Disease 2019: A Rare Case Report

Announcing New NINDS Scientific Director – Jeffrey Diamond, Ph.D.

Advocacy Opportunities

Race, Health & the Public Good: How to Infuse Big Systems with New Ideas

Want the latest news on herpes cure, treatment and prevention?
Sign up for emails to make sure you never miss a thing.

Success! You're on the list.

Leave a Reply